Fundraising FoxAgilis Biotherapeutics
Cambridge, US · Founded 2013 · Delaware corporation · 1 known investors
Find your way into Agilis Biotherapeutics
Sign up to see every warm intro you have to Agilis Biotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Agilis Biotherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Agilis Biotherapeutics was founded in 2013 by G. Houston Hall and Adrian Z. Stecyk.
GH
G. Houston HallManager of the Issuer
Board
AM
Alexander M. SeaverManager of the Issuer
AT
Investors · 1
Reported raises · per SEC filings
Form D private placements$20.7M disclosed across 2 of 3 rounds · 2013–2017
▶$12.7MraisedFeb 2017 · 19 investors · BiotechnologyRule 506(b)
▶$12.7MraisedFeb 2017 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark J. PykettExecutive Officer, Director
- Alexander M. SeaverDirector
- Robert HardieDirector
- Adrian Z. StecykDirector
- G. Houston HallDirector
- Ian RatcliffeDirector
- Offering amount
- $23.3M
- Amount sold
- $12.7M
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$5MofferedFeb 2016 · BiotechnologyRule 506(b)
▶$5MofferedFeb 2016 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alexander M. SeaverDirector
- G. Houston HallDirector
- Adrian Z. StecykDirector
- Mark J. PykettDirector
- Arthur TzianabosDirector
- Offering amount
- $5M
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$8MraisedJan 2014 · 27 investors · BiotechnologyRule 506(b)
▶$8MraisedJan 2014 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- G. Houston HallExecutive Officer
- Alexander M. SeaverExecutive Officer
- Adrian Z. StecykExecutive Officer
- Amount sold
- $8M
- First sale
- Dec 2013
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Agilis Biotherapeutics?
- Agilis Biotherapeutics was founded by G. Houston Hall, Adrian Z. Stecyk in 2013.
- Who are Agilis Biotherapeutics's investors?
- Agilis Biotherapeutics's investors include 5AM Ventures.
- How much funding has Agilis Biotherapeutics raised?
- Agilis Biotherapeutics has disclosed $20.7M raised across 2 of its 3 known rounds.
- Where is Agilis Biotherapeutics headquartered?
- Agilis Biotherapeutics is headquartered in Cambridge, US.